Directing the State Employee Benefits Committee and the Secretary of Human Resources to Engage with Independent Consultants and Other Supply Chain Tactics for Cost Containment of Prescription Drugs for State Employees and Retirees’ Insurance Programs.
It became law on Aug 25, 2025.
- Stage
- Became law
- Sponsors
- 11
- Latest action
- Aug 25, 2025
What it does
This is a Substitute for Senate Joint Resolution No. 7. Like Senate Joint Resolution No. 7, this Substitute directs the State Employees Benefits Committee (SEBC) to utilize specific strategies and policies when interacting and contracting with Pharmacy Benefit Managers (PBM) in order to achieve lower cost \r pharmaceutical drug benefit plans for the State.\r \r This Substitute differs from Senate Joint Resolution No. 7 by clarifying that the SEBC has a duty to consider all of the following strategies and policies when negotiating for pharmaceuticals:\r \r 1. Drug cost transparency.\r 2. Formation of an independent Pharmacy and Therapeutics Committee.\r 3. Any other supply chain tactics such…
Where it stands
This bill passed and is now law.
Introduced (Done)
Committee (Done)
Floor (Done)
Law (Done)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
Once a bill is decided, the questions are about what is done with it in Delaware.